Role of heme in bromine‐induced lung injury. Issue 1 (31st May 2016)

• Record Type: Journal Article
• Authors: Lam, Adam; Vetal, Nilam; Matalon, Sadis; Aggarwal, Saurabh
• Other Names: Laskin Jeffrey D. guestEditor.
• Is Part Of: Annals of the New York Academy of Sciences. Volume 1374:Issue 1(2016)
• Page Start: 105
• Page End: 110
• Publication Date: 2016-05-31
• Subjects: bromine -- heme -- heme oxygenase -- hemopexin -- lung injury; Medical sciences -- Periodicals; Medicine -- Periodicals; Science -- Periodicals; 610
• DOI: 10.1111/nyas.13086
• Languages: English
• ISSNs: 0077-8923

Abstract

Abstract : Bromine (Br2 ) gas inhalation poses an environmental and occupational hazard resulting in high morbidity and mortality. In this review, we underline the acute lung pathology (within 24 h of exposure) and potential therapeutic interventions that may be utilized to mitigate Br2 ‐induced human toxicity. We discuss our latest published data, which suggest that an increase in heme‐dependent tissue injury underlies the pathogenesis of Br2 toxicity. Our study was based on previous findings that demonstrated that Br2 upregulates the heme‐degrading enzyme heme oxygenase‐1 (HO‐1), which converts toxic heme into bilverdin. Interestingly, following Br2 inhalation, heme levels were indeed elevated in bronchoalveolar lavage fluid, plasma, and whole lung tissue in C57BL/6 mice. High heme levels correlated with increased lung oxidative stress, lung inflammation, respiratory acidosis, lung edema, higher airway resistance, and mortality. However, therapeutic reduction of heme levels, by either scavenging with hemopexin or degradation by HO‐1, improved lung function and survival. Therefore, heme attenuation may prove a useful adjuvant therapy to treat patients after Br2 exposure.